<i>HLA</i>-II Locus Heterozygosity Is Associated with Reduced Lung Cancer Risk

Skip Nav Destination

February 29, 2024

Major Finding: HLA-II heterozygosity is associated with reduced lung cancer risk in current and former smokers.

Concept: HLA-II heterozygosity promotes immune control of early cancer evolution through smoking-related neoantigen presentation.

Impact: These data suggest that genetic variation in immunosurveillance can contribute to cancer susceptibility.

DOI:https://doi.org/10.1158/2159-8290.CD-RW2024-035

Article Type: Research Watch

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

HLA-II Locus Heterozygosity Is Associated with Reduced Lung Cancer Risk